Breast Cancer Study Finds Benefit From Aspirin Use Linked To DNA Profiles
Executive Summary
Breast cancer mortality among women who regularly used aspirin decreased 22%-40% for those with unmethylated tumor promoter and progesterone receptor genes, while women with methylated tumor promoter had of 67% all-cause death risk, study finds. Researchers and editorial author say study underscores importance of looking at methylation profiles, or chemical changes, in tumor tissue DNA.
You may also be interested in...
US Health Market In 2019: Unfinished Business Leaves Lasting Impression
Examples of unfinished business from 2019 include no legislation passed to reform OTC monograph program; FDA putting off until May the planned publication of an NPRM to allow firms to submit OTC NDAs with extra-label information to help guide consumers' self-selection; and no OTC naloxone for opioid overdose approved even after FDA's unprecedented step of developing model DFLs sponsors could use for their own label comprehension studies.
Regular Aspirin Use To Prevent Cardiovascular Events Not Advisable For Most Patients – ACC/AHA Guidelines
Aspirin should be used very selectively in the primary prevention of artherosclerotic cardiovascular disease, according to new guidelines from the American College of Cardiology and American Heart Association. While certain higher-risk adults may benefit from regular, preventative aspirin use, those over the age of 70, and any at increased risk of bleeding, should explore lifestyle changes, the groups say.
Ovarian Cancer Risk Cut 23% With Aspirin Use – Harvard Study
Study analyzed follow-up data on 205,498 women from the Nurses’ Health Study started in 1976 and Nurses’ Health Study II opened in 1989; 1,054 of the women developed ovarian cancer.